Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brazil ends 100% dependence on blood product imports worth US$400m

This article was originally published in Clinica

Executive Summary

Brazil’s state-owned blood products and biotechnology firm Hemobr�s has begun to operate the first unit of a state-of-the-art 14-facility blood storage and processing complex. The news marks the beginning of the end of the country’s “100% dependence” on imported haemoderivatives, to become self-sufficient by 2014.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT099472

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel